Alexandria, VA—May 12, 2025—Today, President Trump signed an executive order (EO) directing the administration to communicate most-favored-nation (MFN) drug price targets to pharmaceutical ...

The Association for Clinical Oncology (ASCO) is carefully reviewing the Administration’s Fiscal Year 2026 “skinny” budget proposal, which was released May 2 and contains significant cuts to federal ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

The 2025 ASCO Annual Meeting is The Place to Be—a global gathering where oncology professionals connect, collaborate, and inspire. Known for advancing the field, this must-attend event offers an ...

Two topics critical to the future of cancer care and research—and central to ASCO's mission—were the focus of a pair of oncology podcasts that dropped in April. The NRG Oncology podcast, released on ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers ...

The Association for Clinical Oncology (ASCO) is actively engaged in advocacy to protect Medicaid access for millions of Americans. In 2025, ASCO has partnered with other health care organizations, and ...

The Association for Clinical Oncology (ASCO) is reaching out to the new leaders of federal health agencies to ensure continued progress in cancer care, research, and patient access. In an April 22 ...

All Conquer Cancer research grants are reviewed and evaluated carefully using consistent criteria across all applicants, using criteria that vary depending on the grant mechanism. After the Committee ...

The National Cancer Institute (NCI) and the American Society of Clinical Oncology launched the Teams in Cancer Care Delivery project, with the goal of applying the science of team-based care to ...